In this issue:
Adverse effects of low-dose methotrexate
Real-life treatments and drug survival in systemic sclerosis
Adverse events with oral colchicine
Low-dose prednisone withdrawal in quiescent SLE
Chloroquine/hydroxychloroquine in COVID-19
COVID-19 infection and RA
COVID-19 in immunosuppressant-treated chronic arthritis
All-cause and CV mortality trends in RA
Treat-to-target strategy for RA
Cost-effectiveness of DMARDs vs. TNF inhibitors in RA
Please login below to download this issue (PDF)